TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2

NCT05195060 · clinicaltrials.gov ↗

COMPLETED

Status

1178

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: casirivimab with imdevimab
DRUG: sotrovimab
DRUG: molnupiravir

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)